Company Profile of Inner Mongolia Kangpu Pharmaceutical Co., LTD

Inner Mongolia Kangpu Pharmaceutical Co.,LTD.,funded by Changzhou Kangpu Pharmaceutical Co.,LTD.,was established in July 2019 with a registered capital of 250 million yuan.It is a pharmaceutical high-tech enterprise integrating research and development,production and sales.Production scope:16 non-sterile apis,such as Difenoxate hydrochloride,atropine sulfate, phenhyxol hydrochloride,phenbromarone hydrochloride,aminotoluene acid, pyrithione sodium,chlorpromazine hydrochloride,lidocaine hydrochloride,propranolol hydrochloride,promethazine hydrochloride,sulapride,dipyridamole,metoxlopramide, amsulpiride sulfate,salbutamol sulfate,acotidine hydrochloride,etc.It involves six categories including psychiatry,digestive tract,cardiovascular,antihistamine,antipyretic and analgesic,and nervous system.